Trademark: 79231411
Status Date
Tuesday, December 25, 2018
Registration Number
5635234
Registration Date
Tuesday, December 25, 2018
Filing Date
Tuesday, December 12, 2017
Published for Opposition
Tuesday, October 9, 2018
9 Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for mobile phones, smart phones, portable media players and handheld computers, namely, software for capturing information concerning quality of medication or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals
38 Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies
42 Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and pharmaceuticals used, reactions and events resulting from the use of medication and pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and pharmaceuticals; design of computer software for commercial analysis and reporting
The mark consists of an oval shaped design consisting of two curved band designs at the top and bottom.
Color is not claimed as a feature of the mark.
Dec 25, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 26, 2019
Final Decision Transaction Processed By Ib
Apr 8, 2019
Final Disposition Notice Sent To Ib
Apr 8, 2019
Final Disposition Processed
Mar 25, 2019
Final Disposition Notice Created, To Be Sent To Ib
Dec 25, 2018
Registered-Principal Register
Oct 9, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 9, 2018
Published For Opposition
Oct 6, 2018
Notification Processed By Ib
Sep 19, 2018
Notification Of Possible Opposition Sent To Ib
Sep 19, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 19, 2018
Notification Of Notice Of Publication E-Mailed
Sep 5, 2018
Approved For Pub - Principal Register
Aug 23, 2018
Teas/Email Correspondence Entered
Aug 23, 2018
Correspondence Received In Law Office
Aug 21, 2018
Assigned To Lie
Jul 31, 2018
Teas Change Of Correspondence Received
Jul 31, 2018
Teas Response To Office Action Received
Jun 2, 2018
Refusal Processed By Ib
May 16, 2018
Non-Final Action Mailed - Refusal Sent To Ib
May 16, 2018
Refusal Processed By Mpu
May 15, 2018
Application Filing Receipt Mailed
May 12, 2018
Non-Final Action (Ib Refusal) Prepared For Review
May 11, 2018
Non-Final Action Written
May 9, 2018
Assigned To Examiner
May 9, 2018
New Application Office Supplied Data Entered
May 4, 2018
Limitation From Original Application Entered
May 3, 2018
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
